百能國際(08132.HK)與深電能科技達成儲能電站業務合作
百能國際(08132.HK)公佈,於11月6日與深電能科技集團就可能業務合作訂立不具法律約束力的合作框架協議,深電能科技可向集團轉介有關電化學儲能電站的項目,以供考慮作投資。
若電化學儲能電站的相關項目的投資獲集團批準,集團可投資於該等項目,並享有該等項目的所有權及所產生的收益。集團亦可優先考慮委聘深電能科技按其他各方提供的相同條款設計及建造電化學儲能電站。於完成建設電化學儲能電站後,可委聘深電能科技管理該等電站的營運。
深電能科技由深圳市國電能投資合夥企業持有50%、比亞迪(01211.HK)持有40%及由深圳市殘友集團控股持有10%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.